What is the treatment for impetigo?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Impetigo

For localized impetigo, start with topical mupirocin 2% ointment applied three times daily for 5-7 days; switch to oral antibiotics (dicloxacillin or cephalexin for MSSA, clindamycin or trimethoprim-sulfamethoxazole for MRSA) if the disease is extensive, involves multiple sites, fails topical therapy after 3-5 days, or presents with systemic symptoms. 1, 2

First-Line Topical Treatment

  • Mupirocin 2% ointment applied three times daily is the most effective topical agent for impetigo caused by S. aureus and S. pyogenes, with clinical efficacy rates of 71-93% compared to 35% for placebo 1, 3
  • Treatment duration should be 5-7 days for topical therapy 1, 2
  • Retapamulin 1% ointment applied twice daily for 5 days is an effective alternative for limited disease 2
  • Avoid bacitracin and neomycin as they are considerably less effective and should not be used 1
  • Do not use topical clindamycin cream (the acne formulation) as it lacks FDA indication for impetigo and has insufficient systemic absorption (only 4% bioavailability) to treat bacterial skin infections 1

Indications for Oral Antibiotics

Switch to oral therapy when any of the following are present:

  • Extensive disease or involvement of multiple sites 1, 2
  • Lesions on the face, eyelid, or mouth 1
  • Failure to respond to topical therapy after 3-5 days 1, 2
  • Topical therapy is impractical (e.g., scalp involvement with hair) 2
  • Systemic symptoms present 1, 2
  • Need to limit spread to others in high-transmission settings 1

Oral Antibiotic Selection

For Methicillin-Susceptible S. aureus (MSSA):

  • Dicloxacillin 250 mg four times daily for adults 1, 2
  • Cephalexin 250-500 mg four times daily for adults 1, 2
  • Duration: 5-10 days 1, 2

For Methicillin-Resistant S. aureus (MRSA) - suspected or confirmed:

  • Clindamycin 300-450 mg three times daily for adults (oral formulation, not topical cream) 1, 2
  • Trimethoprim-sulfamethoxazole 1-2 double-strength tablets twice daily for adults 1, 2
  • Doxycycline (avoid in children under 8 years) 2

Critical Pitfall:

Penicillin alone is not effective for impetigo as it lacks adequate coverage against S. aureus 1, 2

When to Obtain Cultures

Obtain cultures from lesions (vesicle fluid, pus, or erosions) in these situations:

  • Treatment failure with appropriate therapy 1, 2
  • MRSA is suspected 1, 2
  • Recurrent infections 1, 2

Special Population Considerations

  • Avoid tetracyclines (doxycycline, minocycline) in children under 8 years of age 1, 2
  • Cephalexin is a safe alternative for pregnant patients 1
  • Oral antibiotic dosing should be adjusted by weight for children 2
  • Clindamycin is the preferred alternative for penicillin-allergic patients 1

Prevention of Spread

  • Keep lesions covered with clean, dry bandages 1, 2
  • Maintain good personal hygiene with regular handwashing 1
  • Avoid sharing personal items that contact the skin 1

Follow-Up and Re-evaluation

  • Re-evaluate if no improvement after 48-72 hours of appropriate therapy 2
  • If impetigo is not responding to appropriate therapy, consider alternative diagnoses 2
  • Adjust therapy based on culture susceptibility results if obtained 2

References

Guideline

Treatment of Impetigo on Hand Lesions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Scalp Impetigo

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.